Altris.AI is an AI-powered ophthalmic image management system that detects 70+ retina pathologies and biomarkers on OCT scans.
Altris.AI's investors include Brinc, Artesian VC, Farmak, Runa Capital, The University of Chicago Booth School of Business.
Altris.AI is headquartered in Chicago, United States.
Altris.AI is an AI-powered ophthalmic image management system that detects 70+ retina pathologies and biomarkers on OCT scans.
Altris.AI is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Altris.AI — Funding & Investors." VCBacked, June 1, 2024, https://www.vcbacked.co/company/altrisai. Accessed September 29, 2026.
VCBacked. (2024). Altris.AI — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/altrisai
{{cite web |title=Altris.AI — Funding & Investors |url=https://www.vcbacked.co/company/altrisai |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated